Navigation Links
Molecular imaging and CT colonography team up to bring comfort to patients

Reston, Va.A study published in the June issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET)a molecular imaging techniquecombined with computer tomography (CT) colonography may provide a suitable alternative for detecting polyps and cancer in the colon. This particular imaging method may be especially desirable for patients because it does not require sedation or bowel preparation.

"One of the first indications of colorectal cancer is often the presence of polyps, which are abnormal tissue growths on the inner lining of the colon or large intestine," said Stuart A. Taylor, M.D., University College London, and lead researcher of the study. "If these polyps are detected non-invasively and without the use of bowel preparation and sedatives, investigation can be much easier on patients who would otherwise undergo colonoscopies."

Until now, the standard diagnostic test for colorectal cancer and polyps has been colonoscopy, whereby a telescopic camera is introduced into the colon via the back passage and passed around the one to two meters of colon to look for abnormalities in the bowel lining.

Although this technique is very effective, it is also invasive and can be uncomfortable for patients, as they need to empty their bowel using laxatives beforehand, they may require sedation during the test and may need to take a whole day off from their normal activities. Strong laxatives can also be harmful to older patients, as they may cause dehydration and disturb their salt levels.

CT colonography (CTC) is an imaging technique that presents a promising, less invasive alternative to colonoscopy. The CTC scan provides images of the lining of the bowel, which has been gently distended with gas, without the need for sedatives. One potentially major advantage of CTC over colonoscopy is its ability to visualize the large bowelwithout the patient having to take strong laxatives. PET scanning produces images of the uptake of blood sugar (glucose) by body tissues. Because cancerous cells tend to take up more blood sugar than normal tissue, these concentrations provide clear evidence of any abnormalities.

This study researched the effectiveness of using a combination of CTC and PET scans without any bowel preparation to detect significant abnormalities in the colon. Although other work has demonstrated that combined PET CTC is technically feasible, most have required patients to undergo complete bowel preparation and only a small number of patients have been studied. The current study is the largest to date investigating combined PET CTC in patients without any bowel preparation.

56 patients agreed to undergo a one-hour CTC and PET scan about two weeks before their scheduled colonoscopy. This was done without the use of laxatives. Patients were also asked to complete a questionnaire to see how they tolerated the tests and which ones they preferred.

The colonoscopy results were then compared with the CTC scan on its own and with the CTC and PET scans combined. The study found that the combined PET CTC scans detected all the important larger polyps found by the invasive colonoscopy technique. In addition, most patients found the combined scan technique more comfortable and preferred it to colonoscopy.

"The work has shown that combined PET CTC is technically feasible, well tolerated by patients and capable of achieving high diagnostic accuracy," said Taylor. "This test would be mainly used in patients less able to tolerate invasive investigations or the preparation required if physicians want to exclude any major pathology in the colon and abdomen."


Contact: Amy Shaw
Society of Nuclear Medicine

Related medicine news :

1. Select Topics in ALL: Molecular Characterization, Approaches to CNS Disease, and Post-remission Transplantation
2. Scientists show how molecular switch helps pancreatic cancer beat drugs
3. New England Journal of Medicine publishes CWRU review of the molecular basis of colorectal cancer
4. Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference
5. Scientists Find Molecular Switch Related to Huntingtons
6. The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer
7. News from the Latest Issue of Molecular Medicine
8. Ground Breaking Molecular Diagnostics Business Appoints New CEO
9. Molecular pathways linked to sex, age affect outcomes in lung cancer
10. SNMs Conjoint Mid-Winter Meetings continue to advance molecular imaging
11. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with the ... 2016 Building Better Radiology Marketing Programs meeting will showcase some of ... 6, 2016, at Caesars Palace in Las Vegas with a pre-conference session on ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop ... not only fulfilling the needs of advisers and clients but going above and ... providing top-tier customer service. However, there's always room for improvement, which is why ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the largest, most successful and prominent nonprofit healthcare organizations in the country. They ... involvement with various organizations, and helped advance the healthcare industry as a whole ...
(Date:11/27/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the ... LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making the ... a version of Asterisk that will receive not only security fixes, but feature ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: